Affiliation:
1. Tokyo Institute of Technology
Abstract
Abstract
Background Ensuring regulatory-compliant manufacturing capability is an essential challenge for new treatment modalities, but its internalisation is not easy for pharmaceutical companies, especially start-ups. This study examines the functions and requirements of contracted development and manufacturing organisations (CDMOs) using the development process of antibody medicines as a case study.
Methods Utilizing PubMed, Cortellis and Patent Integration databases, this study delves into publication and contractual trends in monoclonal antibody drugs (mAbs) development, alongside an analysis of patent filings by CDMOs, offering a comprehensive overview of the evolving landscape in mAbs innovation.
Results In the early stages of mAbs development, dedicated bio firms (DBFs) led R&D with superior drug discovery technology but lacked manufacturing capability, which was complemented by CDMOs. This collaboration was an opportunity for CDMOs to expand their capabilities beyond manufacturing technology into antibody drug candidate discovery and structural optimisation technology. From mid-development onwards, it established a technology platform based on these capabilities and developed and established partnerships with existing pharmaceutical companies, including mega pharma.
Conclusions The impact of institutions and regulations on the innovation process was assessed during this development process. These findings are expected to provide valuable insights into the innovation system for new modalities.
Publisher
Research Square Platform LLC
Reference26 articles.
1. Advancing New Chemical Modalities into Clinical Studies;Blanco MJ;ACS Med Chem Lett,2022
2. Progress in biopharmaceutical development;Kesik-Brodacka M;Biotechnol Appl Biochem,2018
3. Biopharmaceutical benchmarks 2018;Walsh G;Nat Biotechnol,2018
4. Pisano GP. The promise, the reality, and the future of biotech. HBS; 2006.
5. Trends in interorganizational transactions in personalized medicine development;Makino T;Drug Discov Today,2019
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献